MediWound (MDWD) Revenue & Revenue Breakdown
MediWound Revenue Highlights
Latest Revenue (Y)
$18.69M
Latest Revenue (Q)
$4.96M
Main Geography (Y)
USA
MediWound Revenue by Period
MediWound Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $18.69M | -29.48% |
| 2022-12-31 | $26.50M | 11.50% |
| 2021-12-31 | $23.76M | 9.19% |
| 2020-12-31 | $21.76M | -31.54% |
| 2019-12-31 | $31.79M | 834.70% |
| 2018-12-31 | $3.40M | 36.26% |
| 2017-12-31 | $2.50M | 60.21% |
| 2016-12-31 | $1.56M | 159.23% |
| 2015-12-31 | $601.00K | 132.05% |
| 2014-12-31 | $259.00K | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2011-12-31 | - | - |
MediWound generated $18.69M in revenue during NA 2023, up -29.48% compared to the previous quarter, and up 549.43% compared to the same period a year ago.
MediWound Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $4.96M | -7.01% |
| 2023-12-31 | $5.34M | 11.77% |
| 2023-09-30 | $4.78M | 0.06% |
| 2023-06-30 | $4.77M | 25.64% |
| 2023-03-31 | $3.80M | -67.30% |
| 2022-12-31 | $11.62M | 100.21% |
| 2022-09-30 | $5.80M | 24.31% |
| 2022-06-30 | $4.67M | 5.92% |
| 2022-03-31 | $4.41M | -19.68% |
| 2021-12-31 | $5.49M | -13.89% |
| 2021-09-30 | $6.37M | 5.20% |
| 2021-06-30 | $6.06M | 3.59% |
| 2021-03-31 | $5.85M | -12.38% |
| 2020-12-31 | $6.67M | 0.72% |
| 2020-09-30 | $6.63M | 64.51% |
| 2020-06-30 | $4.03M | -9.26% |
| 2020-03-31 | $4.44M | -18.45% |
| 2019-12-31 | $5.44M | 5.88% |
| 2019-09-30 | $5.14M | -75.22% |
| 2019-06-30 | $20.75M | 4400.22% |
| 2019-03-31 | $461.00K | -53.53% |
| 2018-12-31 | $992.00K | 15.62% |
| 2018-09-30 | $858.00K | -16.78% |
| 2018-06-30 | $1.03M | 98.27% |
| 2018-03-31 | $520.00K | -1.89% |
| 2017-12-31 | $530.00K | -28.28% |
| 2017-09-30 | $739.00K | 7.57% |
| 2017-06-30 | $687.00K | 27.22% |
| 2017-03-31 | $540.00K | 25.58% |
| 2016-12-31 | $430.00K | -16.99% |
| 2016-09-30 | $518.00K | 45.51% |
| 2016-06-30 | $356.00K | 40.16% |
| 2016-03-31 | $254.00K | -4.87% |
| 2015-12-31 | $267.00K | 161.76% |
| 2015-09-30 | $102.00K | -38.18% |
| 2015-06-30 | $165.00K | 146.27% |
| 2015-03-31 | $67.00K | -45.97% |
| 2014-12-31 | $124.00K | 169.57% |
| 2014-09-30 | $46.00K | 17.95% |
| 2014-06-30 | $39.00K | -22.00% |
| 2014-03-31 | $50.00K | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | - |
MediWound generated $4.96M in revenue during Q1 2024, up -7.01% compared to the previous quarter, and up 42.73% compared to the same period a year ago.
MediWound Revenue Breakdown
MediWound Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 20 |
|---|---|
| USA | $18.03M |
Latest
MediWound's latest annual revenue breakdown by geography, as of Dec 20: USA (100.00%).
MediWound Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| VCYT | Veracyte | $361.05M | $115.86M |
| STRO | Sutro Biopharma | $153.73M | $25.71M |
| OCUL | Ocular Therapeutix | $58.44M | $14.71M |
| MRUS | Merus | $43.95M | $11.77M |
| FHTX | Foghorn Therapeutics | $34.16M | $7.81M |
| MDWD | MediWound | $18.69M | $4.96M |
| RNA | Avidity Biosciences | $9.56M | $2.04M |
| KRON | Kronos Bio | $6.29M | $2.37M |
| GBIO | Generation Bio | $5.90M | $4.09M |
| SWTX | SpringWorks Therapeutics | $5.45M | $59.73M |
| CRNX | Crinetics Pharmaceuticals | $4.01M | - |
| DYAI | Dyadic | $2.90M | $1.96M |
| INBX | Inhibrx Biosciences | $1.80M | - |
| KROS | Keros Therapeutics | $151.00K | $37.00K |
| LYEL | Lyell Immunopharma | $130.00K | $34.00K |
| AVTE | Aerovate Therapeutics | - | - |
| NKTX | Nkarta | - | - |
| REPL | Replimune Group | - | - |
| SNDX | Syndax Pharmaceuticals | - | $12.50M |
| MLYS | Mineralys Therapeutics | - | - |
| SANA | Sana Bio | - | - |
| GLUE | Monte Rosa Therapeutics | - | $4.70M |